guest ::
| Home > Publications database > Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. > print |
| Home > Publications database > Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. > print |
| 001 | 153861 | ||
| 005 | 20240229123051.0 | ||
| 024 | 7 | _ | |a 10.1016/S1470-2045(19)30856-3 |2 doi |
| 024 | 7 | _ | |a pmid:32105622 |2 pmid |
| 024 | 7 | _ | |a 1470-2045 |2 ISSN |
| 024 | 7 | _ | |a 1474-5488 |2 ISSN |
| 024 | 7 | _ | |a altmetric:76622809 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-00479 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hong, David S |b 0 |
| 245 | _ | _ | |a Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. |
| 260 | _ | _ | |a London |c 2020 |b The Lancet Publ. Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1587034934_8817 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Apr;21(4):531-540 |
| 520 | _ | _ | |a Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a DuBois, Steven G |b 1 |
| 700 | 1 | _ | |a Kummar, Shivaani |b 2 |
| 700 | 1 | _ | |a Farago, Anna F |b 3 |
| 700 | 1 | _ | |a Albert, Catherine M |b 4 |
| 700 | 1 | _ | |a Rohrberg, Kristoffer S |b 5 |
| 700 | 1 | _ | |a van Tilburg, Cornelis M |0 P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271 |b 6 |u dkfz |
| 700 | 1 | _ | |a Nagasubramanian, Ramamoorthy |b 7 |
| 700 | 1 | _ | |a Berlin, Jordan D |b 8 |
| 700 | 1 | _ | |a Federman, Noah |b 9 |
| 700 | 1 | _ | |a Mascarenhas, Leo |b 10 |
| 700 | 1 | _ | |a Geoerger, Birgit |b 11 |
| 700 | 1 | _ | |a Dowlati, Afshin |b 12 |
| 700 | 1 | _ | |a Pappo, Alberto S |b 13 |
| 700 | 1 | _ | |a Bielack, Stefan |b 14 |
| 700 | 1 | _ | |a Doz, François |b 15 |
| 700 | 1 | _ | |a McDermott, Ray |b 16 |
| 700 | 1 | _ | |a Patel, Jyoti D |b 17 |
| 700 | 1 | _ | |a Schilder, Russell J |b 18 |
| 700 | 1 | _ | |a Tahara, Makoto |b 19 |
| 700 | 1 | _ | |a Pfister, Stefan M |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 20 |u dkfz |
| 700 | 1 | _ | |a Witt, Olaf |0 P:(DE-He78)143af26de9d57bf624771616318aaf7c |b 21 |u dkfz |
| 700 | 1 | _ | |a Ladanyi, Marc |b 22 |
| 700 | 1 | _ | |a Rudzinski, Erin R |b 23 |
| 700 | 1 | _ | |a Nanda, Shivani |b 24 |
| 700 | 1 | _ | |a Childs, Barrett H |b 25 |
| 700 | 1 | _ | |a Laetsch, Theodore W |b 26 |
| 700 | 1 | _ | |a Hyman, David M |b 27 |
| 700 | 1 | _ | |a Drilon, Alexander |b 28 |
| 773 | _ | _ | |a 10.1016/S1470-2045(19)30856-3 |g p. S1470204519308563 |0 PERI:(DE-600)2035574-9 |n 4 |p 531-540 |t The lancet |v 21 |y 2020 |x 1470-2045 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:153861 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)143af26de9d57bf624771616318aaf7c |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b LANCET ONCOL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b LANCET ONCOL : 2017 |
| 920 | 1 | _ | |0 I:(DE-He78)B310-20160331 |k B310 |l KKE Pädiatrische Onkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B310-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|